Induction of drug resistance in human rhabdomyosarcoma cell lines is associated with increased maturation: Possible explanation for differentiation in recurrences?

Pediatric and Developmental Pathology

Volumn 5, Issue 3, 2002, Pages 276-282

  Leuschner, Ivo ^a   Heuer, Thomas ^a   Harms, Dieter ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Cell line; Chemosensitivity; Differentiation; Rhabdomyosarcoma

Indexed keywords

CISPLATIN; CYTOTOXIC AGENT; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; MYOSIN;

ARTICLE; CANCER CELL CULTURE; CANCER RECURRENCE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; TUMOR DIFFERENTIATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIFFERENTIATION; CELL DIVISION; CISPLATIN; CYTOSKELETAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM RECURRENCE, LOCAL; RHABDOMYOSARCOMA; TUMOR CELLS, CULTURED;

EID: 0036290076     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10024-001-0132-0     Document Type: Article

References (42)

1. Rhabdomyosarcoma and the undifferentiated sarcomas
2. The third intergroup rhabdomyosarcoma study
3. Cytological "differentiation" in childhood rhabdomyosarcomas following polychemotherapy
4. Rhabdomyosarcoma and related tumors
5. Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs
6. X-radiation-induced differentiation of xenotransplanted human undifferentiated rhabdomyosarcoma
7. Reduced metastatic ability of in vitro differentiated human rhabdomyosarcoma cells
8. Correlation between cell differentiation stage, types of invasion, and hematogenous metastasis in experimental rhabdomyosarcomas
9. Rhabdomyosarcoma of urinary bladder and vagina. A clinicopathologic study with emphasis of recurrent disease. A report of the Kiel Pediatric Tumor Registry and the German CWS Study
10. Misidentified cell
11. Cell identity resolved
12. The role of drugs in cancer treatment
13. A simple method to determine whole cell uptake of radiolabelled oestrogen and progesterone and their subcellular localization in breast cancer cell lines in monolayer culture
14. Studies of conditions and mechanisms of the diphenylamine reaction for colorimetric determination of deoxyribonucleic acid
15. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)
16. Low concentrations of actinomycin D potentially cause therapeutic differentiation in human rhabdomyosarcoma cell line RD
17. In vitro differentiation of rhabdomyosarcomas induced by nickel or by Moloney murine sarcoma virus
18. Fetal calf serum and retinoic acid affect proliferation and terminal differentiation of a rat rhabdomyosarcoma cell line (BA-HAN-1C)
19. Actin, tropomyosin and alpha-actinin as markers of differentiation in human rhabdomyosarcoma cell lines induced with dimethyl sulfoxide
20. In vitro differentiation and proliferation in a newly established human rhabdomyosarcoma cell line
21. All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell lines
22. Terminal differentiation and growth inhibition of a rat rhabdomyosarcoma cell line (BA-HAN-1C) in vitro after exposure to retinoic acid
23. Pathologic features of rhabdomyosarcoma before and after treatment: A clinicopathologic and immunohistochemical analysis
24. Outcome of children with presence of differentiated rhabdomyoblasts at the end of therapy (TX) for rhabdomyosarcoma (RMS)
25. P-glycoprotein in human sarcoma: Evidence for multidrug resistance
26. Immunohistochemical detection of p-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood
27. Cell growth and division
28. Actinomycin D causes multidrug resistance and differentiation in a human rhabdomyosarcoma cell line
29. Actinomycin D treatment leads to differentiation and inhibits proliferation in rhabdomyosarcoma cells
30. Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin
31. P-glycoprotein and resistance to anticancer drugs
32. Expression of p-glycoprotein in soft tissue tumors of childhood. Correlation to treatment response and recurrence rate
33. P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma
34. Inverse expression of mdr-1 and c-myc genes in a rhabdomyosarcoma cell line resistant to actinomycin D
35. Multidrug drug resistance in pediatric sarcomas
36. What's new in cytostatic drug resistance and pathology?
37. Predicting response to cancer chemotherapy: The role of p53
38. The multidrug resistance protein family
39. Multidrug resistance and its reversal
40. Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNA
41. Apoptosis and drug response